Ibrutinib and Relugolix: Interaction Details

Brand names
Ibrutinib
Imbruvica
Relugolix
Orgovyx
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Ibrutinib With Relugolix

What can happen when they are taken together (rated Major)

Increased relugolix exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Because relugolix is a , giving it together with a P-gp should be avoided, since the combination can raise relugolix exposure and, in turn, the likelihood of relugolix-related adverse reactions. When the two cannot be kept apart, relugolix or relugolix/estradiol/norethindrone acetate should be taken first, the doses should be spaced at least 6 hours apart, and adverse reactions should be checked for more often.12

For a brief course of therapy with certain P-gp , relugolix may be paused for a maximum of 2 weeks and then restarted once the P-gp inhibitor has been stopped. Should the interruption in relugolix last longer than 7 days, therapy is restarted with a 360 mg loading dose on day one, followed by 120 mg once daily. In a drug interaction study, giving relugolix (a P-gp substrate) with erythromycin (a P-gp inhibitor) produced a 3.5-fold rise in relugolix and a 2.9-fold rise in its .1

The Ibrutinib and Relugolix Interaction, Explained

Ibrutinib (Imbruvica) can block a protein in your body called , which acts like a pump that helps move relugolix (Orgovyx) out of your system. When that pump is slowed, more relugolix can stay in your body than intended. That may raise the chance of relugolix side effects, such as hot flashes, tiredness, muscle or joint aches, or diarrhea.

This combination is usually avoided, but sometimes both medicines are truly needed. If so, your care team can manage it by timing your doses carefully and checking on you more often. Please keep taking your medicines as prescribed and talk with your pharmacist or doctor about this combination.

Mechanism: Ibrutinib inhibits , reducing efflux of relugolix (a P-gp ) and increasing relugolix systemic exposure. Neither drug's direction is altered by activation.

  • Magnitude: Not studied with ibrutinib specifically. With erythromycin (P-gp ), relugolix rose 3.5-fold and rose 2.9-fold.
  • Severity/evidence: Major; probable. Onset unspecified.
  • Management: Avoid . If unavoidable, give relugolix first, separate from ibrutinib by at least 6 hours, and monitor more frequently for relugolix adverse reactions (e.g., hot flashes, fatigue, musculoskeletal pain, diarrhea). For short P-gp inhibitor courses, relugolix may be interrupted up to 2 weeks. If interrupted more than 7 days, restart with a 360 mg loading dose on day 1, then 120 mg once daily.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Ibrutinib and Relugolix Interact

The likely mechanism

of -mediated efflux transport of relugolix

In short: Ibrutinib slows P-glycoprotein, a pump that moves relugolix out of cells, so more relugolix can stay in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Ibrutinib and Relugolix Interaction

Care teams usually try to avoid using these two medicines together. When both are needed, your team may:

  • Have you take relugolix first, then wait at least 6 hours before taking ibrutinib.
  • Check on you more often for relugolix side effects.
  • In some cases, pause relugolix for a short time and restart it later, possibly with a different first-day dose.

What you can do: Keep taking both medicines exactly as prescribed. Do not change the timing or stop anything on your own. Let your pharmacist or prescriber know you take both, and tell them about any new or worsening side effects.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Ibrutinib or Relugolix need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: ORGOVYX oral tablets, relugolix oral tablets

    A drug interaction study found that giving relugolix (a ) together with erythromycin (a P-gp ) raised relugolix by 3.5-fold and by 2.9-fold.1

Ibrutinib and Relugolix: Common Questions

How serious is the Ibrutinib and Relugolix interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Ibrutinib and Relugolix interaction managed?

Care teams usually try to avoid using these two medicines together. When both are needed, your team may: Have you take relugolix first, then wait at least 6 hours before taking ibrutinib. Check on you more often for relugolix side effects. In some cases, pause relugolix for a short time and restart it later, possibly with a different first-day dose. What you can do: Keep taking both medicines exac… Management is individual — always follow your own care team's guidance.

How far apart should I take Ibrutinib and Relugolix?

The interaction record says to take ibrutinib and relugolix at least 6 hours apart.

Your pharmacist can help you fit this into the times you take your other medicines.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Ibrutinib and Relugolix Interaction

Ask in your own words about taking Ibrutinib and Relugolix together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: ORGOVYX oral tablets, relugolix oral tablets. Sumitomo Pharma America, Inc (per FDA), Marlborough, MA, 2025. DailyMed
  2. Product Information: MYFEMBREE(R) oral tablets, relugolix, estradiol, norethindrone acetate oral tablets. Myovant Sciences Inc (per FDA), Brisbane, CA, 2021. DailyMed
Was this write-up helpful?

Other Serious Interactions of Ibrutinib and Relugolix

Also serious with Ibrutinib

Also serious with Relugolix

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Ibrutinib

With Relugolix

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.